当前位置:首页 - 行情中心 - 拓新药业(301089) - 财务分析 - 现金流量表

拓新药业

(301089)

  

流通市值:29.26亿  总市值:40.70亿
流通股本:9097.63万   总股本:1.27亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金229,605,482.71149,408,894.7668,877,403.51374,096,487.58
  收到的税费返还5,815,039.314,085,687.952,710,713.6830,715,583.13
  收到其他与经营活动有关的现金10,321,516.67,552,218.362,475,514.6113,257,859.56
  经营活动现金流入小计245,742,038.62161,046,801.0774,063,631.8418,069,930.27
  购买商品、接受劳务支付的现金111,190,316.2173,059,052.8743,443,850.6106,663,533.44
  支付给职工以及为职工支付的现金106,136,972.9472,686,028.3238,025,608.78143,870,276.56
  支付的各项税费17,027,745.3614,427,513.1212,056,344.7122,736,643.48
  支付其他与经营活动有关的现金34,176,587.4923,888,841.868,548,364.4142,130,775.87
  经营活动现金流出小计268,531,622184,061,436.17102,074,168.5315,401,229.35
  经营活动产生的现金流量净额-22,789,583.38-23,014,635.1-28,010,536.7102,668,700.92
二、投资活动产生的现金流量:
  收回投资收到的现金725,000,000470,000,000340,000,000610,000,000
  取得投资收益收到的现金3,911,595.042,578,804.381,887,265.553,434,029.35
  处置固定资产、无形资产和其他长期资产收回的现金净额---602,194.76
  投资活动现金流入小计728,911,595.04472,578,804.38341,887,265.55614,036,224.11
  购建固定资产、无形资产和其他长期资产支付的现金34,571,342.5418,597,614.9810,644,850.8383,912,345.51
  投资支付的现金670,000,000435,000,000220,000,000670,000,000
  投资活动现金流出小计704,571,342.54453,597,614.98230,644,850.83753,912,345.51
  投资活动产生的现金流量净额24,340,252.518,981,189.4111,242,414.72-139,876,121.4
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金---31,636,125
  支付其他与筹资活动有关的现金1,224,188.16--936,798.21
  筹资活动现金流出平衡项目0--0
  筹资活动现金流出小计1,224,188.16--32,572,923.21
  筹资活动产生的现金流量净额平衡项目0--0
  筹资活动产生的现金流量净额-1,224,188.16---32,572,923.21
四、汇率变动对现金及现金等价物的影响-154,322.2131,607.96183,629.72828,794.44
五、现金及现金等价物净增加额172,158.76-3,901,837.7483,415,507.74-68,951,549.25
  加:期初现金及现金等价物余额61,781,733.2561,781,733.2561,781,733.25130,733,282.5
  期末现金及现金等价物余额61,953,892.0157,879,895.51145,197,240.9961,781,733.25
补充资料:
  净利润--18,280,549.55--19,884,868.92
  资产减值准备-7,316,298.7-10,678,437.92
  固定资产和投资性房地产折旧-23,902,641.19-43,790,598.62
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-23,902,641.19-43,790,598.62
  无形资产摊销-1,395,802.04-3,600,310.39
  长期待摊费用摊销-434,141.28-833,883.95
  处置固定资产、无形资产和其他长期资产的损失---5,674.6
  固定资产报废损失-277,289.27-1,415,182.76
  公允价值变动损失--755,247.22--875,756.43
  财务费用--54,910.49--778,717.16
  投资损失--1,703,047.95--677,321.82
  递延所得税--3,455,836.94--7,957,780.85
  其中:递延所得税资产减少--2,916,489.5--5,874,886.52
    递延所得税负债增加--539,347.44--2,082,894.33
  存货的减少--13,811,386.09-14,549,733.39
  经营性应收项目的减少--31,143,139.3-72,827,307.25
  经营性应付项目的增加-13,367,576--19,275,087.42
  现金的期末余额-57,879,895.51-61,781,733.25
  减:现金的期初余额-61,781,733.25-130,733,282.5
  现金及现金等价物的净增加额--3,901,837.74--68,951,549.25
公告日期2025-10-292025-08-272025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑